🔬 Latest pharma industry updates 👇
🤝 Jazz Pharmaceuticals will acquire Actio Biosciences, Inc. for up to $1.3B, adding a rare epilepsy drug and expanding its neuroscience pipeline.
🔬 Latest Pharma Industry Updates
Pharma Weekly Updates in a Quick, 2-Minute Read.
Live Last read · last published · next check
Latest posts
🔬 Latest pharma industry updates 👇
🤝 AstraZeneca and Bristol Myers Squibb were reportedly exploring a ~$400B megamerger, but a senior source later said no discussions were ongoing, cooling speculation over one of pharma’s largest potential combinations.
🔬 Latest pharma industry updates 👇
🤝 argenx will acquire Forte Biosciences, Inc. for about $2.2B, adding FB102, a first-in-class anti-CD122 antibody with clinical validation in vitiligo and celiac disease.
🔬 Latest pharma industry updates 👇
🟢 GSK won FDA approval for Jideytro in advanced lung cancer, marking its 1st lung cancer approval, a significant cancer-treatment advance.
🔬 Latest pharma industry updates 👇
🤝Eli Lilly and Company will acquire AtaiBeckley for up to $3.8B, adding a nasal psychedelic for treatment-resistant depression and expanding its neuropsychiatry pipeline.
🔬 Latest pharma industry updates 👇
🤝 Vertex Pharmaceuticals will buy Crinetics Pharmaceuticals for $10B, its largest acquisition ever, expanding into endocrinology with Palsonify.
🔬 Latest pharma industry updates 👇
🤝 Ipsen will buy Kartos Therapeutics, Inc. for up to $1.75B and Memo Therapeutics AG for over €700M to strengthen its rare disease pipeline.
🔬 Latest pharma industry updates 👇
🤝 AbbVie will acquire Apogee Therapeutics for $10.9B, adding immunology assets for atopic dermatitis and asthma.
🔬 Latest pharma industry updates 👇
🤝 Biogen will acquire RayThera for up to $1B, adding preclinical and early immunology small molecules.
🔬 Latest pharma industry updates 👇
This edition is sponsored by AzurBio - supporting biotech and pharma companies looking to enter, understand, and grow in the European market.